Fedha

Beta
Hisa unazofuatilia
Sekta za hisa
Alama
Alama
Bei
Tofauti
Tofauti ya asilimia
Mwenendo wa data
Bei ya Awali
Fungua
Juu
Chini
Kiasi cha mauzo ya hisa
Mtaji wa Soko
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
1,102.181,096.241,103.051,090.35
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
616.24616.24617.68609.10
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
1,189.721,194.741,202.791,188.58
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
1,725.691,730.021,762.991,730.02
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
643.62643.13643.17632.59
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
829.79832.32845.25832.32
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
213.40213.40216.07213.40
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
3,185.923,160.893,178.723,102.60
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
908.94912.57934.91912.57
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
1,478.961,478.171,482.911,466.65
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
2,405.362,390.342,402.532,359.18
BIOCON:NSE
Biocon Ltd
₹ 355.25
-0.77%
(-2.75) Siku 1
24 Apr, 10:00:20 GMT +5:30  ·   INR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya BIOCON...
Fungua
₹ 358.05
Juu
₹ 358.95
Chini
₹ 354.45
Mtaji wa soko
575.27B
Wastani wa kiasi cha mauzo
3.42M
Kiasi cha mauzo ya hisa
elfu 396.49
Gawio
0.14%
Mgawo wa faida wa kila robo mwaka
₹ 0.12
Tarehe ya kutojumuisha gawio
4 Jul 2025
Uwiano wa bei ya hisa na mapato kwa kila hisa
73.25
Juu kwa wiki 52
₹ 424.95
Chini kwa wiki 52
₹ 308.45
EPS
₹ 4.85
Hisa za wawekezaji
600.00M
Idadi ya wafanyakazi
elfu 16
Habari
Kutoka kwenye vyanzo vya wavuti
Wasifu
Biocon Limited is an Indian biopharmaceutical company based in Bengaluru, with U.S. headquarters in Bridgewater, New Jersey. The company was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Biocon's formulations for the Indian market include metabolics, oncology, immunotherapy, and nephrology products. Some of Biocon's key brands in India include INSUGEN, BASALOG, BIOMAb EGFR, BLISTO, CANMAb, Evertor, TACROGRAF, ALZUMAb and KRABEVA. Syngene International Limited is a publicly listed subsidiary of Biocon, operating in the contract research and development organization. Wikipedia
Kuhusu Biocon Ltd
Afisa Mkuu Mtendaji (CEO)Siddharth Mittal
Wafanyakazielfu 16.4
Lilianzishwa29 Nov 1978
Makao makuuBangalore, Karnataka, India
Sekta-
Simu inayofuata baada ya siku baada ya siku 14
Alhamisi, 7 Mei, 23:30
Kipindi cha Kifedha
Robo4 2026
Mapato Yaliyosawazishwa kwa Kila Hisa au Kadirio
-/ (1.17 inakadiriwa)INR
Mapato au Kadirio
-/ (45.09B inakadiriwa)INR
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 4 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari: mapato yajayoMaarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika INR
Loading Previous Earnings...
Taarifa ya mapato
Mapato
Mapato halisi
Thamani zote katika INR
Mac 2025
Jun 2025
Sep 2025
Des 2025
Mapato
44.17B
39.42B
42.96B
41.73B
Gharama ya bidhaa zilizouzwa
22.93B
14.05B
17.72B
13.39B
Gharama ya mapato
22.93B
14.05B
17.72B
13.39B
Gharama za utafiti na maendeleo
-370.00M
-346.00M
-132.00M
-531.00M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
11.62B
8.33B
9.59B
8.75B
Gharama ya uendeshaji
14.18B
22.43B
21.18B
25.16B
Jumla ya gharama za uendeshaji
37.11B
36.48B
38.90B
38.55B
Mapato ya uendeshaji
7.06B
2.94B
4.05B
3.18B
Mapato mengine yasiyo ya uendeshaji
-1.23B
-11.62B
94.00M
1.17B
EBT ikijumuisha vipengee visivyo vya kawaida
4.87B
969.00M
1.71B
-678.00M
EBT bila kujumuisha vipengee visivyo vya kawaida
4.36B
-11.45B
1.23B
2.26B
Gharama ya kodi ya mapato
274.00M
77.00M
385.00M
-160.00M
Kiwango cha kodi kinachotumika
5.63%
7.95%
22.48%
23.60%
Gharama nyingine za uendeshaji
-1.46B
9.89B
6.72B
11.78B
Mapato halisi
3.44B
314.00M
845.00M
1.44B
Kiwango cha faida halisi
7.80%
0.80%
1.97%
3.45%
Mapato kwa kila hisa
2.71
0.26
0.72
2.74
Mapato ya riba na uwekezaji
1.12B
-
235.00M
-
Gharama ya riba
-2.03B
-2.77B
-2.72B
-2.10B
Jumla ya gharama halisi za riba
-912.00M
-2.77B
-2.49B
-2.10B
Gharama za kushuka kwa thamani na za kulipa deni
4.36B
4.55B
4.73B
5.15B
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
11.01B
6.89B
8.69B
7.13B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi

Utafiti

Majukumu yangu
Bado hujaanzisha jukumu lolote
Majukumu yako yataonekana hapa. Ratibu majukumu na uruhusu Google Finance ifanye kazi ukiwa mbali.
Violezo
Muhtasari wa hisa unazofuatilia
Uchanganuzi wa kila siku wa kabla ya soko kufunguliwa wa orodha ya hisa unazofuatilia
Mapato Yajayo
Ripoti za mapato yajayo katika wiki
Mabadiliko ya Bei na Kiasi cha Hisa Kisicho cha Kawaida
Onyo la mapema kuhusu mabadiliko ya kiwango cha miamala leo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi